Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...
For women who undergo a mastectomy, reconstruction is treated almost as a given. We speaks to seven women proudly defying the status quo.
In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...
The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.
The Straits TimesWith Singapore becoming a super-aged nation, helping people stay healthy is more critical than ever.So, the ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results